UNP
50
2
REGN
53
-3
SIG
67
-5
PNR
30
-2
PSA
35
15
CA
15
6
WM
80
6
KMB
42
-2
MO
45
-2
AZO
48
-2
PYPL
32
3
AKAM
58
-3
CSCO
57
3
DD
41
-3
SYY
31
-4
PH
60
-2
CNP
70
2
ICE
63
6
AEE
69
-4
PNW
69
2
UNP
50
2
REGN
53
-3
SIG
67
-5
PNR
30
-2
PSA
35
15
CA
15
6
WM
80
6
KMB
42
-2
MO
45
-2
AZO
48
-2
PYPL
32
3
AKAM
58
-3
CSCO
57
3
DD
41
-3
SYY
31
-4
PH
60
-2
CNP
70
2
ICE
63
6
AEE
69
-4
PNW
69
2
Financhill
Back

RiverNorth Capital and Income Fund Vs. Apogee Therapeutics, Inc. Industry Stock Comparison

Sell
35

RSF
RiverNorth Capital and Income Fund

Last Price:
$14.85
Seasonality Move:
-0.25%
Sell
44

APGE
Apogee Therapeutics, Inc.

Last Price:
$84.40
Seasonality Move:
-11.77%
Sell
35
RiverNorth Capital and Income Fund (RSF) is a Sell

Is RiverNorth Capital and Income Fund a Buy, Sell or Hold?

  • The current RiverNorth Capital and Income Fund [RSF] share price is $14.70. The Score for RSF is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • RSF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Apogee Therapeutics, Inc. (APGE) is a Sell

Is Apogee Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Apogee Therapeutics, Inc. [APGE] share price is $84.34. The Score for APGE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • APGE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RSF Stock Price Chart

What is RiverNorth Capital and Income Fund's stock price today?

  • The RiverNorth Capital and Income Fund share price today is $14.70
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RSF is experiencing selling pressure, which indicates risk of future bearish movement.

APGE Stock Price Chart

What is Apogee Therapeutics, Inc.'s stock price today?

  • The Apogee Therapeutics, Inc. share price today is $84.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APGE is experiencing buying pressure, which is a positive indicator for future bullish movement.

RSF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 54.54 Buy
Chaikin Money Flow: -6926 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.34 - 14.72) Buy
Bollinger Bands (100): (14.37 - 14.63) Buy

APGE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.18 Buy
Relative Strength Index (14 RSI): 64.96 Buy
Chaikin Money Flow: 432550 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (69.1 - 79.44) Buy
Bollinger Bands (100): (66.23 - 78.47) Buy

RSF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.64 Buy
20-day SMA: 14.58 Buy
50-day SMA: 14.49 Buy
200-day SMA: 14.6 Buy
8-day EMA: 14.63 Buy
20-day EMA: 14.58 Buy
50-day EMA: 14.53 Buy
200-day EMA: 14.64 Buy

APGE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 79.91 Buy
20-day SMA: 75.21 Buy
50-day SMA: 71.36 Buy
200-day SMA: 57.28 Buy
8-day EMA: 80.37 Buy
20-day EMA: 76.41 Buy
50-day EMA: 73.33 Buy
200-day EMA: 61.58 Buy

RiverNorth Capital and Income Fund Earnings Growth & RSF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apogee Therapeutics, Inc. Earnings Growth & APGE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.62 per share.

RiverNorth Capital and Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apogee Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):